Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 7:29 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 289–312 of 1,326 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Validation Clear all

Conditions: Newborn Jaundice
Interventions: BiliCam estimated bilirubin (BCB); Device
Lead sponsor: BiliCam, LLC; Industry
Eligibility: 0 Hours to 191 Hours
Enrollment: 203 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Mitochondrial Myopathies, Mitochondrial Diseases
Interventions: Nanosensor; Device
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 18 Years to 65 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Coronary Restenosis
Interventions: Not listed
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older
Enrollment: 761 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Jaundice, Neonatal, Hyperbilirubinemia, Bilirubin-Induced Neurological Dysfunction (BIND)
Interventions: Bilirubin Binding Capacity by Hematofluorometry Validation; Device
Lead sponsor: Stanford University; Other
Eligibility: 6 Hours to 14 Days
Enrollment: 161 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2018
U.S. locations: 2
States / cities: Stanford, California • Lakewood, New Jersey

Conditions: Healthy Population, Chronic Disease
Interventions: Verily Clinical Study Watch, Vivalink ECG Patch, Modus StepWatch 4; Device
Lead sponsor: Verily Life Sciences LLC; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: South San Francisco, California

Conditions: Pregnancy Related
Interventions: Pulsenmore ES home ultrasound; Device
Lead sponsor: PulseNmore; Industry
Eligibility: 18 Years and older
Enrollment: 57 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023
U.S. locations: 2
States / cities: Los Angeles, California • Boston, Massachusetts

Conditions: Arrhythmia, Palpitations, Lightheadedness
Interventions: Alivecor monitor and 14 day event monitor; Device
Lead sponsor: University at Buffalo; Other
Eligibility: 18 Years and older
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Residual Neuromuscular Blockade, Curarization, Postoperative Residual, Postoperative Respiratory Complication
Interventions: Observational Study; Other
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 101,510 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Trauma; Complications, Multiple Organ Failure
Interventions: Traumatized population, Healthy Volunteers; Other
Lead sponsor: University of Florida; Other
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2019
U.S. locations: 2
States / cities: Gainesville, Florida • Seattle, Washington

Conditions: To Determine the Psychometric Properties of the Short Child Occupational Profile
Interventions: Not listed
Lead sponsor: Texas Woman's University; Other
Eligibility: Up to 21 Years
Enrollment: 499 participants
Healthy volunteers: Healthy volunteers not accepted
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Healthy
Interventions: Not listed
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 12 Years and older
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1998 – 2006
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Healthy
Interventions: Chewable aspirin; Other
Lead sponsor: Vanderbilt University; Other
Eligibility: 18 Years and older
Enrollment: 64 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Healthy
Interventions: Avocado; Other
Lead sponsor: Clinical Nutrition Research Center, Illinois Institute of Technology; Industry
Eligibility: 25 Years to 70 Years
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Stroke
Interventions: Not listed
Lead sponsor: Rhode Island Hospital; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Surgery, One-lung Ventilation
Interventions: One-lung ventilation; Other
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Ultrasound Imaging of Anatomical Structures
Interventions: Ultrasound scans; Device
Lead sponsor: IntelligentUltrasound Limited; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Cystic Fibrosis
Interventions: Hyperpolarized Xenon; Drug
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 6 Years to 12 Years
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2025
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Atrial Fibrillation (AF), Atrial Fibrillation Patients Treated With the FARAPULSE™ PFA System, Atrial Fibrillation (Paroxysmal), Pulmonary Vein Isolation
Interventions: AF Recurrence RIsk Assessment post pulmonary vein isolation; Device
Lead sponsor: CathVision ApS; Industry
Eligibility: 21 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Paramus, New Jersey

Conditions: Small Intestine Disease, Small Intestine Cancer, Small Intestinal Ulcer Bleeding, Small Intestine Obstruction, Small Intestine Adenocarcinoma, Small Intestine Polyp
Interventions: Not listed
Lead sponsor: Medtronic - MITG; Industry
Eligibility: Not listed
Enrollment: 3,712 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2025
U.S. locations: 30
States / cities: Birmingham, Alabama • Escondido, California • Valencia, California + 26 more

Conditions: Magnesium Deficiency
Interventions: Applied Kinesiology; Diagnostic Test
Lead sponsor: Anthony Rosner; Other
Eligibility: 18 Years to 75 Years
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Warwick, Rhode Island

Conditions: Establish Normative pH Values in Neonates
Interventions: RightSpot Infant pH Indicator; Device
Lead sponsor: RightBio Metrics; Industry
Eligibility: 24 Weeks to 40 Weeks
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2014
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Low Back Pain, Neck Pain
Interventions: Not listed
Lead sponsor: Ashkan Vaziri; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 5 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: Newton, Massachusetts

Conditions: Recurrent Non-Small Cell Lung Carcinoma, Stage IIIA Non-Small Cell Lung Cancer, Stage IIIB Non-Small Cell Lung Cancer, Stage IV Non-Small Cell Lung Cancer
Interventions: Erlotinib Hydrochloride, Pemetrexed Disodium; Drug
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years and older
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2014
U.S. locations: 268
States / cities: Scottsdale, Arizona • Fort Smith, Arkansas • Antioch, California + 176 more

Conditions: Heart Failure
Interventions: Not listed
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: Boston, Massachusetts

Search by objective public record fields.

BiliCam Clinical Validation Study

Validation of Oxygen Nanosensor in Mitochondrial Myopathy

Whole Genome Association Study to Identify and Validate Genes for Restenosis: CardioGene Validation Proposal

Point-of-Care System for Determination of Bilirubin Capacity in Neonates

Verily Clinical Study Watch Analytical Validation Study

Human Factoring Validation of Pulsenmore ES Device

Validation of an iPhone-based Event Recorder for Arrhythmia Detection

Validation of the REPS Prediction Tool

A Validation of a Genomics Based Prognostic in Severe Trauma

Psychometric / Validation Study

Validation of Methods to Estimate Body Fat

Validation of an Assay to Measure Cyclooxygenase-1 Activity

Validation of Avocatin b as a Biomarker of Food Intake

Validity of a New Stroke Dysphagia Screening Tool

Esophageal Pressure Measurements During One-lung Ventilation

A Study to Collect Imaging Data for the Validation of the Intelligent Ultrasound's ScanNav Anatomy Peripheral Nerve Block (PNB) - US v1.0

Monitoring Response to Orkambi in Cystic Fibrosis Lung Disease by Inhaled Xenon MRI

P-wave Duration and Local Potential as Predictors of AF Recurrence Following Pulmonary Vein Isolation

Prospective Collection of PillCam SB3 Videos and Raw Data Files for Future Developments (SODA)

Validation of the Magnesium Muscle Stretch Test

Product Validation Study of RightSpot Infant pH Indicator for Rapid Bedside Verification of Proper Nasogastric (NG) Tube Placement in Newborn Intensive Care (NICU) Patients

Wearable Spine Assessment in Adults With and Without Low Back or Neck Pain

Pemetrexed Disodium or Erlotinib Hydrochloride as Second-Line Therapy in Treating Patients With Advanced Non-small Cell Lung Cancer

Validation of Electrical Cardiometry Versus Fick Method in Cardiac Output Measurement